Video Experimental Relacionado
Updated: Sep 10, 2025
07:08
Burn Injury-Induced Pain and Depression-Like Behavior in Mice
Published on: September 29, 2021
3.2K
Antimuscarínicos para pacientes con quemaduras: ¿Son útiles o perjudiciales para la recuperación de la sensación?
Zachary H Zamore1, Jeffrey Khong1, Rachana Suresh1
1Department of Plastic and Reconstructive Surgery, Johns Hopkins University School of Medicine, Baltimore, USA.
Burns : journal of the International Society for Burn Injuries
|August 20, 2025
Resumen
El uso de fármacos antimuscarínicos en pacientes con quemaduras se relacionó con una mayor probabilidad de desarrollar parestesia, un indicador potencial de regeneración nerviosa. Se necesitan más estudios para evaluar el impacto funcional de este cambio sensorial.
Área de la Ciencia:
- Investigación de las quemaduras
- Regeneración de los nervios periféricos
- Intervenciones farmacológicas
Sus antecedentes:
- Las quemaduras con frecuencia causan daño a los nervios, lo que provoca dolor, entumecimiento y pérdida de la sensibilidad protectora.
- La regeneración eficaz de los nervios después de las quemaduras es crucial para la recuperación del paciente y la prevención de nuevas lesiones.
- Los medicamentos antimuscarínicos, que se usan comúnmente para la vejiga hiperactiva, son prometedores para apoyar el crecimiento de los nervios.
Objetivo del estudio:
- Investigar la asociación entre el uso de fármacos antimuscarínicos en el momento de la lesión por quemaduras y la posterior regeneración nerviosa.
- Determinar si el tratamiento antimuscarínico influye en la probabilidad de cambios sensoriales después de la quemadura.
Principales métodos:
- Análisis retrospectivo de la base de datos de investigación de TriNetX.
- Identificación de pacientes con quemaduras utilizando los códigos de la CIE-10-CM.
- Comparación de los usuarios de drogas antimuscarínicas con un grupo de control con puntuación de propensión.
- La aparición de parestesia entre 3 y 24 meses después de la lesión como indicador de la regeneración nerviosa.
Principales resultados:
- Los usuarios de Antimuscarinic tenían más del doble de probabilidades de desarrollar parestesia en comparación con los controles, independientemente del método de codificación de la quemadura (área anatómica o TBSA).
- También se observó un aumento en el uso de analgésicos en los usuarios de antimuscarínicos.
- La significación estadística se mantuvo en ambas cohortes (p < 0,001).
Conclusiones:
- Los pacientes con quemaduras que recibieron tratamiento antimuscarínico demostraron una mayor incidencia de parestesia, lo que sugiere una posible regeneración nerviosa.
- Si bien la parestesia puede indicar recuperación sensorial, también podría manifestarse como sensaciones anormales o dolorosas que afectan la calidad de vida.
- Es esencial realizar más investigaciones para determinar los resultados funcionales y la importancia clínica de estos cambios sensoriales.
Videos de Conceptos Relacionados
01:26Cholinergic Antagonists: Therapeutic Uses
871
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
871
01:28Cholinergic Antagonists: Pharmacological Actions
1.2K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.2K
01:24Cholinergic Antagonists: Pharmacokinetics
560
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
560
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
452
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
452
01:22Burn Injuries
2.8K
Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
2.8K
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
828
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
828